Global Bovine-based Collagen for Biomedical Applications Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bovine-based Collagen for Biomedical Applications Sales Market Report 2024
Market Analysis and InsightsGlobal Bovine-based Collagen for Biomedical Applications Market
Collagen is a protein exclusively found in animals, specifically in the connective tissues and skin of mammals.Collagen is primarily extracted from bovine, porcine, chicken, and marine.
Due to the COVID-19 pandemic, the global Bovine-based Collagen for Biomedical Applications market size is estimated to be worth US$ 252 million in 2024 and is forecast to a readjusted size of US$ 378 million by 2034 with a CAGR of 5.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Bone Graft Substitutes accounting for % of the Bovine-based Collagen for Biomedical Applications global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospitals segment is altered to an % CAGR throughout this forecast period.
The United States Bovine-based Collagen for Biomedical Applications market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Bovine-based Collagen for Biomedical Applications include BBI Solutions, Symatese, Gurnet Point Capital, Viscofan BioEngineering, Collagen Solutions, Botiss, Medtronic, Taxus Cardium and KYERON, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Bovine-based Collagen for Biomedical Applications Scope and Market Size
The global Bovine-based Collagen for Biomedical Applications market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Bovine-based Collagen for Biomedical Applications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Bone Graft Substitutes
Collagen-based Scaffolds
Hemostats
Skin Substitutes
Cartilage Repairs
Others
Hospitals
Ambulatory Surgical Centers
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
BBI Solutions
Symatese
Gurnet Point Capital
Viscofan BioEngineering
Collagen Solutions
Botiss
Medtronic
Taxus Cardium
KYERON
Collagen Matrix
Collagen is a protein exclusively found in animals, specifically in the connective tissues and skin of mammals.Collagen is primarily extracted from bovine, porcine, chicken, and marine.
Due to the COVID-19 pandemic, the global Bovine-based Collagen for Biomedical Applications market size is estimated to be worth US$ 252 million in 2024 and is forecast to a readjusted size of US$ 378 million by 2034 with a CAGR of 5.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Bone Graft Substitutes accounting for % of the Bovine-based Collagen for Biomedical Applications global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospitals segment is altered to an % CAGR throughout this forecast period.
The United States Bovine-based Collagen for Biomedical Applications market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Bovine-based Collagen for Biomedical Applications include BBI Solutions, Symatese, Gurnet Point Capital, Viscofan BioEngineering, Collagen Solutions, Botiss, Medtronic, Taxus Cardium and KYERON, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Bovine-based Collagen for Biomedical Applications Scope and Market Size
The global Bovine-based Collagen for Biomedical Applications market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Bovine-based Collagen for Biomedical Applications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Bone Graft Substitutes
Collagen-based Scaffolds
Hemostats
Skin Substitutes
Cartilage Repairs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
BBI Solutions
Symatese
Gurnet Point Capital
Viscofan BioEngineering
Collagen Solutions
Botiss
Medtronic
Taxus Cardium
KYERON
Collagen Matrix
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices